Industry News
BetaStay ahead with AI-powered media monitoring and human quality assurance. Our curated industry insights give you a comprehensive overview of the latest developments in your field
Local & industry wins build trusted proof, SEO signals, and prime national editors.
Medline, a medical technology company, completed its IPO on December 18, 2025, trading on the Nasdaq under "MED." Opening at $29, the stock closed near $41, a 40-percent increase, establishing Medline's valuation around $54 billion and marking the year's largest U.S. debut, according to Medtech Magazine.
Photo by Tim Witzdam on Unsplash
50 articles found
TL;DR: Medtech Magazine featured David Lang, Nordic Head of Intuitive, who aims to broaden patient access to minimally invasive surgery. Lang noted the expansion of robot-assisted surgery globally and the rapid advancement of minimally invasive techniques in Sweden, where Intuitive partners with healthcare and regulatory bodies to promote innovative solutions.
Photo by Fliesentisch Fotograf on Unsplash
EUDAMED, the EU's system for increased medical device transparency and safety, has faced significant implementation delays. Anna-Karin Alm argues these ongoing delays are destabilizing an already strained industry, as stakeholders expected a faster rollout of the database with accessible information about devices, incidents, and trials.
Photo by Pharmacy Images on Unsplash
Medtech Maze CEO Paulina Jonasson predicts that precision medicine will become predominant in medtech by 2026. This transition is enabled by the successful implementation of regulatorily approved AI solutions in healthcare, projected for 2025, and will be further driven by AI-powered image analysis as well as advanced risk profiling, leading to less reliance on general solutions.
Photo by Markus Winkler on Unsplash
Vitrolife is restructuring its Genetic Services division, which will cut 6% of its workforce. This action aims to enhance focus and financial performance, resulting in annual savings of SEK 65 million. Vitrolife is restructuring its Genetic Services division, according to Medtech Magazine. This reorganization will result in a 6% reduction in staff, generating annual cost savings of SEK 65 million. CEO Bronwyn Brophy O’Connor explained that the restructuring will sharpen the division's focus and enhance its financial performance. The move builds upon recent growth and profitability gains and is d.
Photo by National Cancer Institute on Unsplash
Survey of PR challenges among 314 Nordic startup and scaleup companies.
Read the reportTL;DR: The European Commission proposed revisions to the EU's Medical Device Regulation and In Vitro Diagnostic Regulation to modernize and streamline the rules. The current regulations have caused bottlenecks, increased costs, fostered uncertainty, and led to slower approvals, potentially forcing product withdrawals from the European market.
Photo by Marek Studzinski on Unsplash
Doctolib, a French health tech company valued at $6.4 billion in 2022, is in talks for a secondary investment round, with Generation Investment Management considering buying shares from existing investors. The deal could keep Doctolib's valuation relatively flat, while Mistral has overtaken it as France's most valuable startup with a $14 billion valuation.
Photo by Iraj Ishtiak on Unsplash
Intellego board member Johan Möllerström and the former CEO are being investigated by the Swedish Economic Crime Authority for alleged financial crimes, including gross swindling and fraud. The investigation centers on deceptive press releases and financial reports that may have artificially inflated Intellego's valuation, and the probe also impacts Sensodetect due to Intellego's market communications.
Photo by Erik Mclean on Unsplash
A reporter visited Addlife's office near Brunkebergstorg in Stockholm to meet Fredrik Dalborg, who was delayed due to a meeting. After apologizing, Mr. Dalborg pointed out a stack of "The Compounders" books, which he distributes to his professional connections. Upon arriving at Addlife's office, situated near Brunkebergstorg in central Stockholm, a reporter waited in the reception area for Fredrik Dalborg. Mr. Dalborg, delayed by an extended meeting, emerged a few minutes later and apologized for the inconvenience. He then directed the reporter's attention to a stack of books, "The Compounders,".
Photo by National Cancer Institute on Unsplash
Anna Lindström has been named BrainCool's CEO, according to Medtech Magazine. With a background that includes leadership positions at Invent Medic Sweden and Xaga Surgical, and sales roles at Alfa Laval and Alufluor, Ms. Lindström's extensive experience will guide BrainCool's commercial growth and market expansion efforts.
Photo by Camila Mofsovich on Unsplash
TL;DR: Sahlgrenska University Hospital is the first in Sweden to use heat-based endoscopic radiofrequency ablation (EUS RFA) to treat benign, insulin-producing tumors in the pancreas called insulinomas. This offers a less invasive treatment option for patients who traditionally require surgery for the rare condition which causes excessive insulin production and subsequent hypoglycemia.
Photo by Natanael Melchor on Unsplash
TL;DR: A California jury ruled that Johnson & Johnson must pay $40 million to two women who claimed the company's baby powder caused their ovarian cancer, based on a Reuters report. This verdict is the latest development in lawsuits concerning Johnson & Johnson's talc products.
Photo by Milad Fakurian on Unsplash
TL;DR: Catharina Barkman points out that fractured and inaccessible data makes it difficult to measure healthcare accessibility and results. It's difficult for individuals to find clear answers about healthcare outcomes and wait times due to the complexity of locating relevant information on regional websites, especially for those unfamiliar with the system.
Photo by Erik Mclean on Unsplash
On December 15, 2025, Philips acquired Spectrawave, a U.S. company based in Bedford, Massachusetts, that specializes in AI-assisted intravascular imaging technology for heart conditions, and employs over 70 individuals. The deal incorporates Spectrawave's Hypervue and X1-FFR systems, which use OCT, NIRS, and AI to enhance diagnostic capabilities for cardiovascular disease.
Photo by Craig Cameron on Unsplash
Yen-po (Harvey) Chin, a Harvard Medical School postdoctoral fellow, co-founded AESOP Technology and DermAI with Professor Li Yu-Chuan. AESOP Technology uses data analytics and machine learning to identify medication errors, while DermAI applies similar technologies to analyze skin conditions, particularly for detecting irregular moles.
Photo by Mufid Majnun on Unsplash
Flow Neuroscience, a company based in Malmö, has secured FDA premarket approval for their electric brain stimulation headset, which treats depression. U.S. clinics can now prescribe this headset for adult patients with moderate to severe major depressive disorder, making it the first FDA-approved at-home medical device for this purpose.
Photo by Nick Fewings on Unsplash
Cenova, a Mjölby-based company, has transformed from a component manufacturer to a strategic development and manufacturing partner in medical technology, prompting expansion due to increasing market demand. This includes scaling production, implementing automation, and planning a new manufacturing facility to capitalize on opportunities in the evolving medical technology field.
Photo by ZHENYU LUO on Unsplash
Cenova, a medical technology company in Mjölby, is expanding due to market demand by investing in automation and a new facility. The company assembles complete medical systems using external components like pumps and proprietary parts, positioning itself as a strategic partner for complex medtech solutions.
Photo by ZHENYU LUO on Unsplash
Suturion, a Swedish medical device company, has received CE marking for its surgical suturing device intended for abdominal wall closure after surgery. With this regulatory approval secured, Suturion is now cleared to commercially launch and distribute the device throughout the European market, offering its advanced surgical solution to healthcare providers in the region.
Photo by Sakarie Mustafe Hidig on Unsplash
Mark Waugh will become OssDsign's CEO starting January 1, 2026, joining from Medacta USA where he was SVP – Commercial. With over 20 years in orthopedics from companies like Smith & Nephew and Medtronic, Waugh will work from OssDsign's U.S. office and his home in Indiana, concentrating on U.S. market growth.
Photo by Navy Medicine on Unsplash
GE Healthcare unveiled the Photonova Spectra CT system at RSNA, utilizing "Deep Silicon" photon-counting detectors initially created in Sweden. This new system aims to deliver ultra-high-resolution imaging due to its superior spectral and spatial resolution. GE Healthcare has also filed a premarket notification in the U.S. for the device.
Photo by Rosen Stoyanov on Unsplash
GE Healthcare unveiled its Photonova Spectra CT scanner at RSNA in Chicago, featuring Deep Silicon detector technology. The scanner offers exceptional spectral and spatial resolution for ultra-high-resolution imaging with broad coverage and is based on technology from Sweden. GE Healthcare has submitted a pre-market notification for the Photonova Spectra in the United States.
Photo by Enrico Fumagalli on Unsplash
Optisense Care created the Zen Seat, a smart toilet seat equipped with radar, to monitor bowel habits in elderly and dementia care facilities. The Zen Seat tracks emptying patterns to inform caregivers about patient health. Helsingborg will be the first city to officially test the Zen Seat's effectiveness.
Photo by Kelsey Todd on Unsplash
Swedish investment firm Amplex launched a SEK 1.05 billion public takeover bid for life science company Addvise Group, aiming to delist it from the stock exchange, according to Medtech Magazine. Amplex's offer, at SEK 1.65 per share and SEK 0.49 per warrant, signifies a 42% premium over Addvise's recent valuation.
Photo by Vitaly Gariev on Unsplash
Mark Waugh will become the new CEO of OssDsign AB, starting January 1, 2026, succeeding Morten Henneveld. Waugh, previously with Medacta USA and other firms, brings extensive experience to OssDsign, operating from the U.S. to drive growth in America and Europe.
Photo by Navy Medicine on Unsplash
Philips is expanding the commercial availability of its Lumiguide 3D Device Guidance technology in Europe and the U.S. Lumiguide, integrated into the Azurion platform, is the first light-based system for real-time navigation within the body, offering a radiation-free alternative to X-ray imaging for minimally invasive procedures.
Photo by Craig Cameron on Unsplash
Trelleborg, an industrial group, has expanded its focus on medical technology and biopharmaceuticals by opening three new facilities globally. These facilities are dedicated to serving these industries. *Medtech Magazine* reports that Trelleborg, a global industrial group, has recently opened three new facilities worldwide dedicated to medical technology and biopharmaceuticals. These investments follow the formation of...
Photo by Galen Crout on Unsplash
Anna Lefevre Skjöldebrand, CEO of Swedish Medtech, stated in a December 8, 2025 interview that increased digitalization and advancements in precision diagnostics will cause more healthcare delivery to occur within patients' homes. She also noted that geopolitical factors, preparedness, and global competitiveness will influence the medtech industry's evolution alongside internal innovations.
Photo by Vitaly Gariev on Unsplash
TL;DR: Cellavision has secured CE marking for its Bone Marrow Aspirate (BMA) Application, designed for use with Cellavision's DC-1 instrument. The software solution is intended for clinical laboratories to automate and standardize the morphological analysis of bone marrow samples, aiding in the assessment of blood abnormalities.
Photo by Harpreet Singh on Unsplash
Anna Maria Braun is the CEO of B. Braun Melsungen, a medical device company founded in 1839, and owns 10% of the company. Under her father's leadership, the company grew from $24 million in annual sales to $8 billion and employs over 64,000 people globally, offering infusion solutions, surgical instruments, and other technologies.
Photo by Peter Poluch on Unsplash
Torben Nielsen is resigning as President and CEO of Boule Diagnostics, a role he began in April 2024. Nielsen led a restructuring that cut costs, stopped in-house hematology instrument development, shifted to a partner-based portfolio, and altered financial reporting to segment the company into Diagnostics and OEM Clinical Diagnostic Solutions.
Photo by Malcolm Choong 鍾声耀 on Unsplash
Medtech Magazine is releasing industry profiles with executive insights on past performance and future strategies, looking ahead to 2026. A deeper strategic analysis is not yet available, as the full content will be published after the holidays. Medtech Magazine has released a preview of its upcoming industry profiles, featuring insights from leading executives regarding their expectations for 2026. The profiles will explore leaders' perspectives on both past performance and future strategies. Further strategic analysis is unavailable at this time, pending the release of the full content following the holiday season.
Photo by BoliviaInteligente on Unsplash
Tove Christiansson is now the CEO of Careium, according to Medtech Magazine. Christiansson is also Chairman of Swedish Medtech and currently leads the Hjälpmedel business area within the Medcap Group, where she serves as CEO of a portfolio company. According to Medtech Magazine, Tove Christiansson has been named the new Chief Executive Officer of Careium. Christiansson also serves as Chairman of Swedish Medtech and currently leads the Hjälpmedel business area within the Medcap Group, where she is also CEO of a portfolio company. Specifics regarding Careium's strategic objectives for this.
Photo by Marco Bicca on Unsplash
Tove Christiansson, the current Chair of Swedish Medtech, will become Careium's CEO in Q2 2026, succeeding the interim CEO in place since August. Christiansson brings experience from Medcap, including her role as Head of Aids and CEO of Abilia, and is recognized by Careium's Chairman as a commercially-driven leader with expertise in the welfare technology sector and M&A-driven growth.
Photo by Markus Winkler on Unsplash
RISE MNB's article highlights strategies for manufacturers to expedite MDR certification, achieving it in 6-9 months compared to the 12-18 month average. They attribute faster certification to proactive strategies like integrating regulatory compliance early in product development and actively engaging in open communication with notified bodies throughout the process.
Photo by Dimitri Karastelev on Unsplash
Pernilla Norman writes in Medtech Magazine that the EU's "digital decade" legislation, including the "omnibus package" intended to simplify administrative processes, could paradoxically increase complexity for medtech companies through revisions to the GDPR and the AI Act. Multiple acts like the Digital Markets Act, Digital Services Act, NIS2 Directive, Data Act, and Cyber Resilience Act may create an increasingly complex regulatory environment, which could undermine the EU's simplification goal.
Photo by Milad Fakurian on Unsplash
Magloy Tech, a Singaporean medtech startup founded by Manakari, Parande, and Professor Gupta, created OrthoMag, a biocompatible magnesium alloy bone implant. Designed to dissolve over time, OrthoMag eliminates the need for a second surgery to remove it, leading to reduced patient risk, with Magloy Tech also receiving funding from firms such as Origgin Ventures and Startup SG Tech.
Photo by TSD Studio on Unsplash
Addlife, through its Labtech business, acquired Danish companies Pharmacold A/S and Opitek International ApS, according to Medtech Magazine. Pharmacold, specializing in temperature-controlled storage, will be integrated into Addlife's Holm & Halby subsidiary to broaden their product portfolio and offerings. Addlife, a company known for strategic acquisitions, has further expanded its Labtech business area with the acquisition of Danish companies Pharmacold A/S and Opitek International ApS, according to Medtech Magazine. The acquisition of Pharmacold A/S, a specialist in temperature-controlled storage solutions for the pharmaceutical and healthcare industries, represents a key strategic.
Photo by Jeff Trierweiler on Unsplash
TL;DR: Getinge CEO Mattias Perjos stated in Medtech Magazine that Liberation Day's new tariffs and currency fluctuations are challenging the medtech industry, potentially threatening patient access to crucial healthcare solutions. Simultaneously, artificial intelligence and digitalization are rapidly transforming operational practices in both healthcare and medtech.
Photo by EqualStock on Unsplash
Sweden proposes amending the Freedom of the Press Act and the Fundamental Law on Freedom of Expression to comply with the EU's accessibility directive. This will broaden accessibility requirements for products and services protected under media constitutional laws, including e-books and e-commerce, with an effective date of January 1, 2027.
Photo by Annie Spratt on Unsplash
Swedish healthcare faces persistent inefficiencies, as reported by Catharina Barkman in Medtech Magazine. Reviews confirm issues with managing medical referrals, leading to misplacement, delays, redundant testing, and increased costs. Barkman highlights the lack of tracking for referrals, akin to package delivery, revealing communication breakdowns that impede timely patient care.
Photo by Kristine Wook on Unsplash
Elekta, a medical tech firm, will cut around 450 jobs globally, as revealed in their report on Wednesday, November 26, 2025. This restructuring follows underperformance despite market advantages and a relevant product line, impacting management positions. According to a report in Medtech Magazine, Elekta, a medical technology company, is implementing a restructuring plan that will eliminate approximately 450 positions worldwide. The announcement, included in the company's quarterly report released on Wednesday, November 26, 2025, cited underperformance relative to its potential despite operating within a favorable market and possessing a pertinent.
Photo by Lightsaber Collection on Unsplash
Surgical Science's stock plummeted by over 60% after Intuitive Surgical ended an agreement to integrate their simulation software into all new Da Vinci 5 robots. Intuitive Surgical now intends to offer Surgical Science's software to select clients only and include their own simulation package in the remaining Da Vinci 5 systems, impacting the market's perception of Surgical Science.
Photo by Natanael Melchor on Unsplash
Claes Lindahl, Intellego Technologies' ex-CEO, has been detained due to heightened suspicion of aggravated fraud, according to a Stockholm District Court ruling. The investigation, led by State Prosecutor Thomas Hertz, is scrutinizing Intellego's public communications since 2025 to ascertain if investors were intentionally misled regarding the company's market value. Nasdaq is also in the process of delisting Intellego Technologies from the First North exchange.
Photo by Jonathan Gong on Unsplash
Get daily industry insights via newsletter. Optionally join the beta for full access to all Heartspace modules.
Get curated industry insights delivered to your inbox. Choose your sectors of interest.
Whether you prefer DIY tools or done-for-you services, we can help you get media coverage.